Chronic inducible urticaria (CIU) constitutes a challenging dermatological disorder characterized by recurrent hives triggered by various stimuli. The global market for CIU treatments is estimated to experience rapid expansion over the upcoming few years, driven by influences such as increasing prevalence of CIU, improved diagnostic capabilities, a